The investment marks the first ever funding round of the UKPRP.
9 May 2019
Access three decades-worth of global neurodegenerative disease research funding
17 Jul 2018
The study in rats reversed changes due to cerebral small vessel disease
5 Jul 2018
An international research team funded by the MRC has identified three new genes linked to the risk of Alzheimer's disease.
18 May 2018
Feeding the flies a molecule, cAMP, reinvigorates transport in older neurons
29 Mar 2018
UK – USA Neuro Partnership Symposium kicks off today
22 Mar 2018
MRC secures £40million for new UK Dementia Research Institute (UK DRI) building
12 Mar 2018
Spotlight on: Dementia
About neurodegenerative diseases and dementia
Around 50 million people live with dementia worldwide - with one new case every 3 seconds. 850,000 people are estimated to be living with dementia in the UK. Neurodegenerative diseases are incurable conditions where nerve cells gradually die. These diseases give rise to a decline in memory, thinking and language skills often referred to as dementia.
Neurodegeneration and dementia research are key priorities for the MRC. We spend millions of pounds of taxpayers’ money every year funding the very best researchers and outstanding science to better understand and treat these diseases. Read more about neurodegeneration and what we are doing to help tackle dementia.
Makis Tsioras is a PhD student at the UK Dementia Research Institute, University of Edinburgh. He explains his research in the fight against dementia.
- The power of big data
Ed Pinches, from Alzheimer’s Research UK, tells us why access to large data sets is so important in our fight against dementia.
- Pushing dementia research through US-UK collaboration
We’re running a symposium to encourage joining up of UK early career researchers and National Institutes of Health (NIH) researchers working in neurodegeneration.